Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07424079 · ClinicalTrials.gov registry record · NA
Metacognitive Strategy Training Intervention for Transition-Age Youth With Cerebral Palsy
A NA study, sponsored by University of Missouri-Columbia.
- Not yet
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT07424079: Clinical Trial NA study, sponsored by University of Missouri-Columbia.
NCT07424079 is a NA study that has not yet begun recruiting, run by University of Missouri-Columbia. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07424079, a NA study, has not yet begun recruiting, sponsored by University of Missouri-Columbia.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This exploratory randomized controlled trial will examine the feasibility and preliminary effects of a remote PREP intervention compared to an attention control for transition-age youth with cerebral palsy and their caregivers. Youth-caregiver dyads will complete remote baseline assessments and be randomized to a 12-week intervention or attention control, with weekly virtual sessions. Feasibility outcomes will be primary, with secondary outcomes exploring preliminary efficacy. Post-intervention assessments and optional interviews will be conducted remotely to capture outcomes and participant experiences.
Primary Outcome
Measure of intervention acceptability. Self-report Likert scale from 1 -completely disagree to 5 - completely agree
Interventions
- BEHAVIORAL Attention Control Condition
- BEHAVIORAL Pathways and Resources for Engagement and Participation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-05-15 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What is known before NCT07424079 opens enrollment
NCT07424079 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Attention Control Condition is the first listed.
NCT07424079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07424079 about?
NCT07424079 is a clinical study titled "Metacognitive Strategy Training Intervention for Transition-Age Youth With Cerebral Palsy". This exploratory randomized controlled trial will examine the feasibility and preliminary effects of a remote PREP intervention compared to an attention control for transition-age youth with cerebral palsy and their caregivers. Youth-caregiver dyads will complete remote baseline assessments and be r...
What is the current status of trial NCT07424079?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-05-15. Estimated completion is 2027-02-28.
What interventions are being tested in trial NCT07424079?
The interventions under investigation include: Attention Control Condition (BEHAVIORAL), Pathways and Resources for Engagement and Participation (BEHAVIORAL).
Who is sponsoring clinical trial NCT07424079?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07424079's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI